Skip to main content
Premium Trial:

Request an Annual Quote

MediChem Awarded NIH Grant to Further Protein Crystallization Effort

NEW YORK, June 13 – Medichem Life Sciences’ Emerald BioStructures division was awarded a Phase II grant from the National Institutes of Health for development of protein crystallization tools, the company announced Wednesday.

The SBIR Phase II grant follows a Phase I grant that supported Emerald’s development of its EmeraldEngine protein crystallization technology platform, which includes robotic automation, software and databases, and expression and membrane crystallization technologies. The Phase II grant is titled “Crystallization Tools for Structural Genomics.”

“Protein crystallization is currently the rate-limiting step in structural proteomics,” MediChem CEO Michael Flavin said in a statement. “Our proprietary technologies enable us to crystallize proteins faster than ever before. This Phase II grant will fund the development of technologies that speed up the process even more.” 

After protein crystallization, Emerald, via a proprietary user agreement, uses Argonne National Laboratory’s Advanced Photon Source to collect X-ray diffraction data and obtain a high resolution rendering of the proteins’ three-dimensional structures.

Chicago-based MediChem acquired Emerald in June 2000. The size of the grant was not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more